Study points to a possible new pathway toward a vaccine against MRSA

New research led by NYU Langone Medical Center has uncovered why a particular strain of Staphylococcus aureus — known as HA-MRSA — becomes more deadly than other variations. These new findings open up possible new pathways to vaccine development against this bacterium, which the Centers for Disease Control and Preventions says accounts for over 10,000 deaths annually, mostly among hospital patients. —> Read More